217 related articles for article (PubMed ID: 32691511)
1. Ablation of sensory nerves favours melanoma progression.
Prazeres PHDM; Leonel C; Silva WN; Rocha BGS; Santos GSP; Costa AC; Picoli CC; Sena IFG; Gonçalves WA; Vieira MS; Costa PAC; Campos LMCC; Lopes MTP; Costa MR; Resende RR; Cunha TM; Mintz A; Birbrair A
J Cell Mol Med; 2020 Sep; 24(17):9574-9589. PubMed ID: 32691511
[TBL] [Abstract][Full Text] [Related]
2. Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression.
Costa PAC; Silva WN; Prazeres PHDM; Picoli CC; Guardia GDA; Costa AC; Oliveira MA; Guimarães PPG; Gonçalves R; Pinto MCX; Amorim JH; Azevedo VAC; Resende RR; Russo RC; Cunha TM; Galante PAF; Mintz A; Birbrair A
Acta Neuropathol Commun; 2021 Nov; 9(1):183. PubMed ID: 34784974
[TBL] [Abstract][Full Text] [Related]
3. Melanoma's connections to the tumour microenvironment.
Brandner JM; Haass NK
Pathology; 2013 Aug; 45(5):443-52. PubMed ID: 23851614
[TBL] [Abstract][Full Text] [Related]
4. Sensory Nerves Impede the Formation of Tertiary Lymphoid Structures and Development of Protective Antimelanoma Immune Responses.
Vats K; Kruglov O; Sahoo B; Soman V; Zhang J; Shurin GV; Chandran UR; Skums P; Shurin MR; Zelikovsky A; Storkus WJ; Bunimovich YL
Cancer Immunol Res; 2022 Sep; 10(9):1141-1154. PubMed ID: 35834791
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53 drives neuron reprogramming in head and neck cancer.
Amit M; Takahashi H; Dragomir MP; Lindemann A; Gleber-Netto FO; Pickering CR; Anfossi S; Osman AA; Cai Y; Wang R; Knutsen E; Shimizu M; Ivan C; Rao X; Wang J; Silverman DA; Tam S; Zhao M; Caulin C; Zinger A; Tasciotti E; Dougherty PM; El-Naggar A; Calin GA; Myers JN
Nature; 2020 Feb; 578(7795):449-454. PubMed ID: 32051587
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Sensory Neurons on Melanoma Growth In Vivo.
Keskinov AA; Tapias V; Watkins SC; Ma Y; Shurin MR; Shurin GV
PLoS One; 2016; 11(5):e0156095. PubMed ID: 27227315
[TBL] [Abstract][Full Text] [Related]
7. Tumour Microenvironment in Skin Carcinogenesis.
Georgescu SR; Tampa M; Mitran CI; Mitran MI; Caruntu C; Caruntu A; Lupu M; Matei C; Constantin C; Neagu M
Adv Exp Med Biol; 2020; 1226():123-142. PubMed ID: 32030681
[TBL] [Abstract][Full Text] [Related]
8. A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection.
Klimkiewicz K; Weglarczyk K; Collet G; Paprocka M; Guichard A; Sarna M; Jozkowicz A; Dulak J; Sarna T; Grillon C; Kieda C
Cancer Lett; 2017 Jun; 396():10-20. PubMed ID: 28288873
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-stroma interactions: structural and functional aspects.
Ruiter D; Bogenrieder T; Elder D; Herlyn M
Lancet Oncol; 2002 Jan; 3(1):35-43. PubMed ID: 11905603
[TBL] [Abstract][Full Text] [Related]
10. Nerve input to tumours: Pathophysiological consequences of a dynamic relationship.
Hutchings C; Phillips JA; Djamgoz MBA
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188411. PubMed ID: 32828885
[TBL] [Abstract][Full Text] [Related]
11. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
[TBL] [Abstract][Full Text] [Related]
12. The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model.
Möser CV; Meissner M; Laarmann K; Olbrich K; King-Himmelreich TS; Wolters MC; Geisslinger G; Niederberger E
Biochem Pharmacol; 2016 Mar; 103():64-73. PubMed ID: 26793999
[TBL] [Abstract][Full Text] [Related]
13. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves.
Siebenhaar F; Magerl M; Peters EM; Hendrix S; Metz M; Maurer M
J Allergy Clin Immunol; 2008 Apr; 121(4):955-61. PubMed ID: 18158175
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Jacobs JF; Nierkens S; Figdor CG; de Vries IJ; Adema GJ
Lancet Oncol; 2012 Jan; 13(1):e32-42. PubMed ID: 22225723
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
16. The tumour immune landscape and its implications in cutaneous melanoma.
Attrill GH; Ferguson PM; Palendira U; Long GV; Wilmott JS; Scolyer RA
Pigment Cell Melanoma Res; 2021 May; 34(3):529-549. PubMed ID: 32939993
[TBL] [Abstract][Full Text] [Related]
17. Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression.
Nakahara T; Oba J; Shimomura C; Kido-Nakahara M; Furue M
J Invest Dermatol; 2016 Jan; 136(1):146-53. PubMed ID: 26763434
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles.
Lima LG; Oliveira AS; Campos LC; Bonamino M; Chammas R; Werneck C; Vicente CP; Barcinski MA; Petersen LC; Monteiro RQ
Thromb Haemost; 2011 Oct; 106(4):712-23. PubMed ID: 21800005
[TBL] [Abstract][Full Text] [Related]
19. Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells.
Albinet V; Bats ML; Huwiler A; Rochaix P; Chevreau C; Ségui B; Levade T; Andrieu-Abadie N
Oncogene; 2014 Jun; 33(26):3364-73. PubMed ID: 23893239
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk Between Sensory Nerves and Cancer in Bone.
Yoneda T; Hiasa M; Okui T
Curr Osteoporos Rep; 2018 Dec; 16(6):648-656. PubMed ID: 30343404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
